Eton Pharma Q3 2022 revenue $3.2M (+315% YoY); net loss narrows to $3.0M

Eton Pharmaceuticals, Inc.

2022-Q3 EPS reported -$0.40 revenue$12,753,000

Product sales and royalties $3.2M, up 315% YoY and 37% sequentially, 7th straight sequential growth.
Net loss $3.0M ($0.12/share) vs $6.1M ($0.24/share) prior year; gross profit $2.0M vs $0.1M.
ALKINDI SPRINKLE sales grew 183% YoY and 19% QoQ; Carglumic Acid sales up 40% QoQ.
Acquired Betaine Anhydrous, a third FDA-approved rare disease product, expected accretive in 2023.
Zonisade FDA approval triggered $5M milestone payment, to be recognized in Q4 2022; cash $13.4M.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Eton Pharmaceuticals, Inc. reported third quarter ended September 30, 2022 results: revenue $3.2 million, net income Net loss of $3.0 million or $0.12 per basic and diluted share, EPS $0.12 per basic and diluted share.

Period: third quarter ended September 30, 2022
Revenue: $3.2 million
Net income: Net loss of $3.0 million or $0.12 per basic and diluted share
EPS: $0.12 per basic and diluted share
Result: reported results

Exact text from the filing

and Recent Business Highlights Reported seventh straight quarter of sequential growth in product sales and royalty revenue. Eton reported total third quarter 2022 revenue of $3.2 million, comprised entirely of product sales and royalty revenue, representing growth of 315% over the prior year and 37% over the second quarter of 2022. Continued strong growth in

View on SEC.gov

Browse all earnings releases →

Eton Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-22-031355

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.